Skip to main content
. 2020 Dec 4;26(3):623–642. doi: 10.1007/s10741-020-10038-w

Fig. 4.

Fig. 4

Schematic representation of myocardial energy consumption. Figure 3a: Myocardial energetics in healthy heart under resting conditions. Figure 3b: Myocardial energetics as a consequence of heart failure and type 2 diabetes. Figure 3c: Changes in myocardial energetics with the use of SGLT2-inhibitor therapy in patients with heart failure and type 2 diabetes Abbreviations: ATP-adenosine triphosphate; BCAA-branch chain amino acid; FFA-free fatty acid; HF-heart failure; ROS-reactive oxygen species; SGLT2- sodium-glucose cotransporter subtype 2; T2DM- type 2 diabetes mellitus